A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19.

Journal: Scientific reports
PMID:

Abstract

The COVID-19 pandemic is impressively challenging the healthcare system. Several prognostic models have been validated but few of them are implemented in daily practice. The objective of the study was to validate a machine-learning risk prediction model using easy-to-obtain parameters to help to identify patients with COVID-19 who are at higher risk of death. The training cohort included all patients admitted to Fondazione Policlinico Gemelli with COVID-19 from March 5, 2020, to November 5, 2020. Afterward, the model was tested on all patients admitted to the same hospital with COVID-19 from November 6, 2020, to February 5, 2021. The primary outcome was in-hospital case-fatality risk. The out-of-sample performance of the model was estimated from the training set in terms of Area under the Receiving Operator Curve (AUROC) and classification matrix statistics by averaging the results of fivefold cross validation repeated 3-times and comparing the results with those obtained on the test set. An explanation analysis of the model, based on the SHapley Additive exPlanations (SHAP), is also presented. To assess the subsequent time evolution, the change in paO2/FiO2 (P/F) at 48 h after the baseline measurement was plotted against its baseline value. Among the 921 patients included in the training cohort, 120 died (13%). Variables selected for the model were age, platelet count, SpO2, blood urea nitrogen (BUN), hemoglobin, C-reactive protein, neutrophil count, and sodium. The results of the fivefold cross-validation repeated 3-times gave AUROC of 0.87, and statistics of the classification matrix to the Youden index as follows: sensitivity 0.840, specificity 0.774, negative predictive value 0.971. Then, the model was tested on a new population (n = 1463) in which the case-fatality rate was 22.6%. The test model showed AUROC 0.818, sensitivity 0.813, specificity 0.650, negative predictive value 0.922. Considering the first quartile of the predicted risk score (low-risk score group), the case-fatality rate was 1.6%, 17.8% in the second and third quartile (high-risk score group) and 53.5% in the fourth quartile (very high-risk score group). The three risk score groups showed good discrimination for the P/F value at admission, and a positive correlation was found for the low-risk class to P/F at 48 h after admission (adjusted R-squared = 0.48). We developed a predictive model of death for people with SARS-CoV-2 infection by including only easy-to-obtain variables (abnormal blood count, BUN, C-reactive protein, sodium and lower SpO2). It demonstrated good accuracy and high power of discrimination. The simplicity of the model makes the risk prediction applicable for patients in the Emergency Department, or during hospitalization. Although it is reasonable to assume that the model is also applicable in not-hospitalized persons, only appropriate studies can assess the accuracy of the model also for persons at home.

Authors

  • Rita Murri
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore- Dipartimento di Sicurezza e Bioetica Sede di Roma, Italy.
  • Jacopo Lenkowicz
    Istituto di Radiologia, Universitá Cattolica del Sacro Cuore, Largo F.Vito 1, 00168 Rome, Italy.
  • Carlotta Masciocchi
    Istituto di Radiologia, Universitá Cattolica del Sacro Cuore, Largo F.Vito 1, 00168 Rome, Italy.
  • Chiara Iacomini
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Massimo Fantoni
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore- Dipartimento di Sicurezza e Bioetica Sede di Roma, Italy.
  • Andrea Damiani
  • Antonio Marchetti
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Paolo Domenico Angelo Sergi
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Giovanni Arcuri
    Department of Health Technology, IRCCS Fondazione Policlinico A. Gemelli, 00168 Rome, Italy.
  • Alfredo Cesario
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Stefano Patarnello
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Massimo Antonelli
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Rocco Bellantone
    U.O. Chirurgia Endocrina e Metabolica, Policlinico "A. Gemelli", Università Cattolica del Sacro Cuore, L.go A. Gemelli 8, 00168 Rome, Italy.
  • Roberto Bernabei
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Stefania Boccia
    Institute of Public Health, Section of Hygiene, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Paolo Calabresi
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Andrea Cambieri
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Roberto Cauda
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore- Dipartimento di Sicurezza e Bioetica Sede di Roma, Italy.
  • Cesare Colosimo
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Filippo Crea
    Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli, 8, 00168 Largo A. Gemelli, Italy. filippo.crea@unicatt.it.
  • Ruggero De Maria
    Università Cattolica Sacro Cuore, Rome, Italy.
  • Valerio De Stefano
    Institute of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Francesco Franceschi
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Antonio Gasbarrini
    Gastroenterology Department, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Ornella Parolini
    Università Cattolica Sacro Cuore, Rome, Italy.
  • Luca Richeldi
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Maurizio Sanguinetti
    Institute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Andrea Urbani
    Sezione di Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Maurizio Zega
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Giovanni Scambia
    Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy.
  • Vincenzo Valentini
    Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy.